Fludarabine Phosphate Injection USP 50 mg is indicated for the treatment of adult patients with B-cell chronic lymphocyticleukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen.
There are many generic manufacturers in India who manufactureFludarabine Phosphate Injection USP 50 mg including United Biotech (P) Ltd etc.
3s corporation is Supplier,Exporter ,Wholesaler for Fludarabine Phosphate Injection USP 50 mg in India.
Fludarabine for injection was associated with severe neurologic effects, including blindness, coma, and death. This severe central nervous system toxicity occurred in 36% of patients treated with doses approximately four times greater (96 mg/m²/day for 5-7 days) than the recommended dose. Similar severe central nervous system toxicity, including coma, seizures, agitation and confusion, has been reported in patients treated at doses in the range of the dose recommended for chronic lymphocytic leukemia.
Call your doctor at once if you have a serious side effect such as:
signs of infection such as fever, chills, sore throat, flu symptoms, easy bruising or bleeding (nosebleeds, bleeding gums), loss of appetite, nausea and vomiting, mouth sores, or unusual weakness;
pale or yellowed skin, dark colored urine;
cough with yellow or green mucus, stabbing chest pain.